CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...